Introduction: Ebullism is the pathophysiological process that occurs as a result of exposures to extremely low ambient pressures, traditionally below 47 mmHg (<0.9 psi, ∼63,000 ft/19,202 m equivalent). However, this field of research has made minimal progress since the 1940s-1960s, when the physiology of high altitude/space operations was being explored. This lack of progress is in part because it is thought of as invariably lethal and also because it requires unique facilities to simulate these environments. As a result, no standardized time/pressure profiles or animal models have been established.

Methods: A rodent animal model (N = 20) was exposed to rapid depressurization as low as 0.3 mmHg for up to 2 min; controls were placed in the chamber but not exposed to a pressure change. Autopsies were performed to characterize the pathophysiology of ebullism at extreme altitudes.

Results: A three-tiered pressure approach was developed that allows for varying degrees of exposure (pressure and time). Although previous studies focused on exposures above or below the Armstrong Line (∼63 kft), we noted significant thermal impacts due to exceeding the water triple point (∼120 kft).

Discussion: This initial study highlights the different pathophysiological regimes that exist beyond Armstrong's line and subdivides ebullism exposures into two different classes, which can be operationally associated with cabin vs. suit depressurization events. These are now presented as Type A Complex Ebullism and Type B Simple Ebullism. The former is characterized by a combination of barotrauma, hypoxia, ebullism, and decompression sickness, while the latter presents as only ebullism. Garbino A, Nusbaum D, Goughnour S, Dalal S, Carminati M-VG, Clark J. Rodent model for high altitude and ebullism exposure studies. Aerosp Med Hum Perform. 2025; 96(3):198-205.

Download full-text PDF

Source
http://dx.doi.org/10.3357/AMHP.6509.2025DOI Listing

Publication Analysis

Top Keywords

rodent model
4
model high
4
high altitude
4
altitude ebullism
4
ebullism exposure
4
exposure studies
4
studies introduction
4
introduction ebullism
4
ebullism pathophysiological
4
pathophysiological process
4

Similar Publications

Glaucoma, a leading cause of irreversible blindness, is characterized by the progressive loss of retinal ganglion cells (RGCs) and optic nerve damage, often associated with elevated intraocular pressure (IOP). Retinoid X receptors (RXRs) are ligand-activated transcription factors crucial for neuroprotection, as they regulate gene expression to promote neuronal survival via several biochemical networks and reduce neuroinflammation. This study investigated the therapeutic potential of 9-cis-13,14-dihydroretinoic acid (9CDHRA), an endogenous retinoid RXR agonist, in mitigating RGC degeneration in a high-IOP-induced experimental model of glaucoma.

View Article and Find Full Text PDF

Spermidine alleviates copper-induced oxidative stress, inflammation and cuproptosis in the liver.

FASEB J

March 2025

State Key Laboratory of Swine and Poultry Breeding Industry, College of Animal Science and Technology, Sichuan Agricultural University, Chengdu, P. R. China.

Copper exposure poses potential detrimental effects on both public and ecosystem health. Spermidine, an antioxidant, has shown promise in reducing oxidative stress and inflammation within the liver. However, its specific role in mitigating copper-induced hepatic cuproptosis and disturbances in copper metabolism remains unexplored.

View Article and Find Full Text PDF

Innate and adaptive immunity are intricately linked to the pathogenesis of ulcerative colitis (UC), with dysregulation of the Treg/Th17 balance and M2/M1 macrophage polarization identified as critical factors. Artesunate (ARS) has previously been shown to alleviate UC by inhibiting endoplasmic reticulum stress (ERS). To further investigate the regulatory effects of ARS on immune dysregulation associated with colitis and the role of ERS in this process, an experimental colitis model was established using dextran sulfate sodium (DSS).

View Article and Find Full Text PDF

Introduction: CD47 is highly expressed on cancer cells and triggers an anti-phagocytic "don't eat me" signal when bound by the inhibitory signal regulatory protein α (SIRPα) expressed on macrophages. While CD47 blockade can mitigate tumor growth, many CD47 blockers also bind to red blood cells (RBCs), leading to anemia. Maplirpacept (TTI-622, PF-07901801) is a CD47 blocking fusion protein consisting of a human SIRPα fused to an IgG4 Fc region and designed to limit binding to RBCs.

View Article and Find Full Text PDF

Cross-protectivity of henipavirus soluble glycoprotein in an model of Nipah virus disease.

Front Immunol

March 2025

Specialised Microbiology and Laboratories, United Kingdom Health Security Agency (UKHSA), Salisbury, Wiltshire, United Kingdom.

Introduction: Nipah virus (NiV) is one of a group of highly pathogenic viruses classified within the Henipavirus genus. Since 2012 at least 11 new henipa-like viruses have been identified, including from new locations and reservoir hosts; the pathogenicity of these new viruses has yet to be determined, but two of them have been associated with morbidity, including fatalities.

Methods: The efficacy and cross-reactivity of two vaccine candidates derived from the soluble glycoproteins of both NiV and Hendra virus (HeV) was evaluated in our recently established hamster model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!